Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Chandra Bhagat Pharma Ltd (NSE: CBPL), ISIN INE07QQ01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
CBPL last traded at ₹49.45 (-5.00%), with a 52-week range of ₹29.70 to ₹52.99 (as of 22 Sep 2026).
Shareholding as of Sep 2025: promoters 72.19%, FIIs 0.61%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 65/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.